If 2021 set the stage for the next few years’ worth of developments in surgical robotics, then it stands to reason 2022 will pay off on some of those actions.
One of those actions is the continued development of new technologies in the space. Distalmotion made progress on this front -raising $90 million in a series E round to support the worldwide commercialization of its surgical robot Dexter. Revival Healthcare Capital led the round with participation from 415 CAPITAL (415), as well as existing investors.
